34βE12 cytokeratin immunodetection in the differential diagnosis of neuroendocrine carcinomas of the breast

Applied Immunohistochemistry and Molecular Morphology

Volumn 9, Issue 3, 2001, Pages 229-233

  Papotti, M ^a   Sapino, A ^a   Righi, L ^a   Chiappone, S ^a   Bussolati, G ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

Breast; Clone 34 E12; High molecular weight cytokeratin; Immunohistochemistry; Neuroendocrine carcinoma

Indexed keywords

CYTOKERATIN; DIAGNOSTIC AGENT; KERATIN; TUMOR MARKER;

ARTICLE; BREAST CARCINOMA; CANCER DIAGNOSIS; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; DIGESTIVE SYSTEM CANCER; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOASSAY; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; NEUROENDOCRINE TUMOR; PRIORITY JOURNAL; RESPIRATORY TRACT CANCER; SMALL CELL CARCINOMA; BREAST TUMOR; CHEMISTRY; METABOLISM; MOLECULAR WEIGHT; PATHOLOGY;

BREAST NEOPLASMS; DIAGNOSIS, DIFFERENTIAL; HUMANS; KERATINS; MOLECULAR WEIGHT; NEUROENDOCRINE TUMORS; TUMOR MARKERS, BIOLOGICAL;

EID: 0034741809     PISSN: 10623345     EISSN: None     Source Type: Journal    
DOI: 10.1097/00022744-200109000-00006     Document Type: Article

References (29)

1. Expression of the neuroendocrine phenotype in carcinomas of the breast
2. Primary carcinoid tumor of the breast. A report of eight patients
3. Endocrine markers in argyrophilic carcinomas of the breast
4. Neuroendocrine differentiation in carcinomas of the breast. A study of 51 cases
5. Correlative study on neuroendocrine differentiation and presence of somatostatin receptors in breast carcinomas
6. Chromogranin A and B gene expression in carcinomas of the breast
7. Carcinomas of the breast with endocrine differentiation: A review
8. Solid papillary carcinoma of the breast, a form of intraductal carcinoma with endocrine differentiation frequently associated with mucinous carcinoma
9. Endocrine differentiation in mucoid carcinoma of the breast
10. Detection of Chromogranin A mRNA in small cell lung carcinoma using a new, highly sensitive in situ hybridization method with a non-radioisotope oligonucleotide probe
11. Detection of Chromogranin A mRNA in small cell lung carcinoma using a new, highly sensitive in situ hybridization method with a nonradioisotope oligonucleotide probe
12. Utility of cytokeratin immunostaining in separating pulmonary adenocarcinomas from colonic adenocarcinomas
13. Immunocytochemical staining of fine needle aspiration biopsies of the liver as a diagnostic tool for hepatocellular carcinoma
14. The catalog of human cytokeratins: Patterns of expression in normal epithelia, tumors and cultured cells
15. Distinction of basaloid squamous cell carcinoma from adenoid cystic and small cell undifferentiated carcinoma by immunohistochemistry
16. 34βE12 cytokeratin immunodetection in the differential diagnosis of small cell tumors in lung biopsy specimens
17. Use of keratin 34BE12 as an adjunct in the diagnosis of mammary intraepithelial neoplasiaductal type-benign and malignant intraductal proliferations
18. The role of immunocytochemical markers in the differential diagnosis of proliferative and neoplastic lesions of the breast
19. Immunohistochemical analysis of pleomorphic lobular carcinoma: Higher expression of p53 and chromogranin and lower expression of ER and PgR
20. Primary oat cell (neuroendocrine) carcinoma of the breast
21. Blocking of endogenous avidin-binding activity in immunohistochemistry. The use of egg whites
22. Retrieved endogenous biotin: A novel marker and a potential pitfall in diagnostic immunohistochemistry
23. Monoclonal antibodies to human intermediate filament proteins. III Analysis of tumors
24. Value of cytokeratin 5/6 immunostaining in distinguishing epithelial mesothelioma of the pleura from lung adenocarcinoma
25. Chromogranin A gene expression in non-small cell lung carcinomas
26. Chromogranin gene expression in colorectal adenocarcinomas
27. Divergent differentiation in prostatic carcinoma
28. Divergent differentiation in neuroendocrine lung tumors
29. Somatostatin receptor subtypes sst1, sst2, sst3, and sst5 expression in human pituitary, gastroenteropancreatic and mammary tumors: Comparison of mRNA analysis with receptor autoradiography